The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 05, 2023

Filed:

Oct. 31, 2017
Applicant:

Medinno Inc., Gyeonggido-do, KR;

Inventors:

Yun Sil Chang, Seoul, KR;

Won Soon Park, Seoul, KR;

So Yoon Ahn, Seoul, KR;

Dong Kyung Sung, Seoul, KR;

Assignee:

MEDINNO INC., Gyeonggido-do, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/28 (2015.01); A61K 35/51 (2015.01); A61P 25/28 (2006.01); C12N 5/0775 (2010.01); A61K 9/00 (2006.01); A61K 35/12 (2015.01); A61K 35/50 (2015.01);
U.S. Cl.
CPC ...
A61K 35/28 (2013.01); A61K 9/0019 (2013.01); A61K 9/0085 (2013.01); A61K 35/12 (2013.01); A61K 35/50 (2013.01); A61K 35/51 (2013.01); A61P 25/28 (2018.01); C12N 5/0665 (2013.01); C12N 2501/734 (2013.01);
Abstract

The present invention relates to a pharmaceutical composition for preventing or treating neonatal hypoxic ischemic encephalopathy (HIE), comprising thrombin-treated stem cells or exosomes derived therefrom as an active ingredient, and a method for producing the same. According to the present invention, the thrombin-treated stem cell or the exosome derived therefrom has an increased expression of growth factors, immunoregulatory factors, antioxidation factors, or regeneration factors compared to a group not treated with thrombin and also enhances a neuronal apoptosis inhibitory effect, and thus has an advantage in that the therapeutic effect thereof on neonatal hypoxic ischemic encephalopathy (HIE) is excellent.


Find Patent Forward Citations

Loading…